Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
143M
-
Number of holders
-
73
-
Total 13F shares, excl. options
-
32.9M
-
Shares change
-
+910K
-
Total reported value, excl. options
-
$692M
-
Value change
-
+$24.4M
-
Number of buys
-
42
-
Number of sells
-
-25
-
Price
-
$21.04
Significant Holders of Dyne Therapeutics, Inc. - Common Stock (DYN) as of Q2 2021
87 filings reported holding DYN - Dyne Therapeutics, Inc. - Common Stock as of Q2 2021.
Dyne Therapeutics, Inc. - Common Stock (DYN) has 73 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 32.9M shares
of 143M outstanding shares and own 23.07% of the company stock.
Largest 10 shareholders include MPM ASSET MANAGEMENT LLC (4.95M shares), WELLINGTON MANAGEMENT GROUP LLP (4.01M shares), Vida Ventures Advisors, LLC (2.96M shares), CITADEL ADVISORS LLC (2.92M shares), RA CAPITAL MANAGEMENT, L.P. (2.81M shares), Logos Global Management LP (2.05M shares), BlackRock Inc. (1.97M shares), VANGUARD GROUP INC (1.21M shares), FRANKLIN RESOURCES INC (1.04M shares), and HHLR ADVISORS, LTD. (1M shares).
This table shows the top 73 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.